10x Genomics (TXG) Revenue (2017 - 2025)

10x Genomics has disclosed Revenue across 9 years of filings, most recently posting $642.8 million for FY2025.

• Revenue for Q1 2026 came in at $150.8 million, down 2.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $638.8 million (up 2.26% YoY), and the FY2025 annual result was $642.8 million, up 5.25% from the prior year.
• Revenue came in at $642.8 million for FY2025 at 10x Genomics, up from $610.8 million in the prior year.
• In the past five years, Revenue ranged from a high of $642.8 million in FY2025 to a low of $490.5 million in FY2021.
• The 5-year median for Revenue is $610.8 million (2024), against an average of $575.8 million.
• Across the five-year window, Revenue jumped 64.13% in 2021 and slipped 1.28% in 2024, its largest moves.
• 10x Genomics' Revenue stood at $490.5 million in 2021, then advanced by 5.28% to $516.4 million in 2022, then rose by 19.81% to $618.7 million in 2023, then slipped by 1.28% to $610.8 million in 2024, then climbed by 5.25% to $642.8 million in 2025.
• The last three Revenue figures came in at $642.8 million (FY2025), $610.8 million (FY2024), and $618.7 million (FY2023), per Business Quant data.